BE856860A - Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation - Google Patents

Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation

Info

Publication number
BE856860A
BE856860A BE179384A BE179384A BE856860A BE 856860 A BE856860 A BE 856860A BE 179384 A BE179384 A BE 179384A BE 179384 A BE179384 A BE 179384A BE 856860 A BE856860 A BE 856860A
Authority
BE
Belgium
Prior art keywords
androstan
derivatives
preparing
products obtained
products
Prior art date
Application number
BE179384A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BE856860A publication Critical patent/BE856860A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE179384A 1976-07-16 1977-07-15 Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation BE856860A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
BE856860A true BE856860A (fr) 1978-01-16

Family

ID=5983514

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179384A BE856860A (fr) 1976-07-16 1977-07-15 Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation

Country Status (18)

Country Link
US (1) US4179336A (fr)
JP (1) JPS5315493A (fr)
AT (1) AT363196B (fr)
BE (1) BE856860A (fr)
CH (3) CH627190A5 (fr)
CS (1) CS200517B2 (fr)
DD (4) DD132439A5 (fr)
DE (1) DE2632677A1 (fr)
DK (1) DK142372C (fr)
FR (4) FR2365588A1 (fr)
GB (1) GB1585786A (fr)
HU (4) HU182681B (fr)
IE (1) IE45304B1 (fr)
IT (1) IT1077339B (fr)
NL (1) NL7706638A (fr)
SE (1) SE440779B (fr)
SU (1) SU980628A3 (fr)
YU (1) YU164277A (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (fr) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
ES2725808T3 (es) * 2003-05-23 2019-09-27 Nektar Therapeutics Derivados de PEG que contienen dos cadenas de PEG
KR101293278B1 (ko) * 2009-10-29 2013-08-09 주식회사 한독 신규 혈관누출 차단제
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2013056181A1 (fr) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. Composés 19-nor-prégnane 3,3-disubstitués, compositions et utilisations associées
EP3392260B1 (fr) 2012-12-18 2022-09-21 Washington University Stéroïdes neuroactifs substitués 19-alkoxy-17, utiles dans des procédés de traitement
EP2956466A4 (fr) * 2013-02-15 2016-11-02 Univ Washington Stéroïdes énantiomères neuroactifs susbtitués en position 15, 16 et 17, utilisés comme modulateurs de récepteurs gaba de type a
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
WO2014169831A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
DK2986624T3 (da) 2013-04-17 2020-06-29 Sage Therapeutics Inc Neuroaktive 19-nor-steroider til terapeutisk anvendelse
JP6470258B2 (ja) 2013-04-17 2019-02-13 セージ セラピューティクス， インコーポレイテッド １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法
CA2918735C (fr) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Steroides neuroactifs, compositions, et leurs utilisations
WO2015027227A1 (fr) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et utilisations
WO2015195962A1 (fr) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Stéroïdes neuroactifs, leurs compositions et utilisations
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
JP6909155B2 (ja) 2014-10-16 2021-07-28 セージ セラピューティクス， インコーポレイテッド Ｃｎｓ障害を処置するための組成物および方法
PT3224269T (pt) 2014-11-27 2020-06-01 Sage Therapeutics Inc Composições e métodos para tratamento de distúrbios do snc
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
WO2018013615A1 (fr) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c7, c12 et c16 et méthodes d'utilisation associées
WO2020243488A1 (fr) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Stéroïdes neuroactifs et compositions associées

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (fr) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
DK142372C (da) 1981-03-23
HU179344B (en) 1982-10-28
US4179336A (en) 1979-12-18
DD136141A5 (de) 1979-06-20
JPS6117477B2 (fr) 1986-05-07
DD132439A5 (de) 1978-09-27
CS200517B2 (en) 1980-09-15
IE45304L (en) 1978-01-16
DE2632677C2 (fr) 1988-06-16
FR2372175A1 (fr) 1978-06-23
DK323677A (da) 1978-01-17
DD137235A5 (de) 1979-08-22
SE440779B (sv) 1985-08-19
FR2365588A1 (fr) 1978-04-21
JPS5315493A (en) 1978-02-13
FR2372176A1 (fr) 1978-06-23
SE7708192L (sv) 1978-01-17
DD136142A5 (de) 1979-06-20
HU182789B (en) 1984-03-28
AT363196B (de) 1981-07-10
FR2365588B1 (fr) 1982-06-25
IE45304B1 (en) 1982-07-28
FR2372174A1 (fr) 1978-06-23
CH627190A5 (fr) 1981-12-31
SU980628A3 (ru) 1982-12-07
DE2632677A1 (de) 1978-01-26
CH629503A5 (de) 1982-04-30
GB1585786A (en) 1981-03-11
YU164277A (en) 1982-08-31
NL7706638A (nl) 1978-01-18
IT1077339B (it) 1985-05-04
CH629222A5 (de) 1982-04-15
HU182790B (en) 1984-03-28
ATA504677A (de) 1980-12-15
HU182681B (en) 1984-02-28
DK142372B (da) 1980-10-20

Similar Documents

Publication Publication Date Title
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
BE860971A (fr) Procede de preparation de n,n'-methylenebis-(0,0-diaryl n-phosphonomethylglycinonitriles, nouveaux produits ainsi obtenus et leur utilisation
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
BE843248A (fr) Procede de preparation de phtalonitrile, et produit obtenu
BE834443A (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4 -pyranones-2
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE841285A (fr) Procede de preparation d'acetoacetyl-arylamides
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
BE842940A (fr) Procede de preparation d'oxaphospholannes-1,2,
LU80346A1 (fr) Procede de preparation d'un produit alimentaire ameliore
IT1146228B (it) Procedimento per preparare 2,6-dialchil-n-alcossimetil-2-cloro-acetanilidi e prodotto ottenuto
BE855371A (fr) Procede de preparation de 1,1-difluorethylene
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
FR2333805A1 (fr) Procede de preparation de n,n'-bis-trimethylsilyluree
BE841471A (fr) Procede de preparation d'humulone et produit obtenu
BE852700R (fr) Procede de preparation d'oxaphospholannes-1,2
FR2310998A1 (fr) Procede de preparation de la 2,5-dimethoxy-4-chloraniline
FR2307781A1 (fr) Procede de preparation d'acenaphtenes
BE858387A (fr) Procede pour la preparation de 2,3-cycloalkenopyridines et produits obtenus
BE841577A (fr) Procede de preparation de derives de 21-hydroxy-16-pregnen-20-one, et produits obtenus
FR2334654A1 (fr) Procede de preparation d'halogeno-nitrobenzenes
BE848388A (fr) Procede de preparation de monohydrate d'ethercarboxylate et nouveau produit ainsi obtenu,
BE877695A (fr) Derives de 2,4,6-triiodo-benzene, leur procede de preparation et leur utilisation
FR2306195A1 (fr) Procede de preparation d'un a-amido-acide et produit obtenu

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHERING A.G.

Effective date: 19920731